GeneDx Announces Heidi Chen as Chief Legal Officer and Corporate Secretary
GeneDx Holdings Corp. - Class A (WGS)
Company Research
Source: Business Wire
Veteran Legal Executive from Zoetis and Pfizer Joins GeneDx Executive Leadership Team to Lead Legal, Compliance and Policy Functions STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced the appointment of Heidi Chen as Chief Legal Officer, effective November 25, 2024. In her role, Heidi will report to Katherine Stueland, CEO and President, and will serve on the executive leadership team.With over 30 years of experience, Heidi will lead all legal, compliance, and policy functions at GeneDx and will provide strategic counsel on corporate governance, intellectual property, regulatory matters, federal policy, compliance and more.“With a massive transformation behind us and a clear runway for growth ahead, Heidi brings the expertise and leadership needed to guide GeneDx into this next chapter, particularly given the changing landscape in healthcare,” said Stueland. “Heidi is a celebrated and wel
Show less
Read more
Impact Snapshot
Event Time:
WGS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
WGS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
WGS alerts
High impacting GeneDx Holdings Corp. - Class A news events
Weekly update
A roundup of the hottest topics
WGS
News
- GeneDx to Participate in Upcoming Investor ConferenceBusiness Wire
- GeneDx Fuels Rare Disease Drug Discovery with Launch of GeneDx DiscoverBusiness Wire
- Meet the Healthcare Stock That Produced Nvidia-Sized Gains in Less Than a Year [Yahoo! Finance]Yahoo! Finance
- New GeneDx Study Reveals Racial Disparities in Genetic Diagnosis Due to Systemic Barriers, Not Diagnostic YieldsBusiness Wire
- GeneDx to Highlight Key Research Findings at American Society of Human Genetics (ASHG) Annual MeetingBusiness Wire
WGS
Earnings
- 10/29/24 - Miss
WGS
Sec Filings
- 11/21/24 - Form 4/A
- 11/21/24 - Form 4
- 11/21/24 - Form 144
- WGS's page on the SEC website